Witztum JL - Search Results

1

Targeted molecular probes for imaging atherosclerotic lesions with magnetic resonance using antibodies that recognize oxidation-specific epitopes.

Briley-Saebo KC, Shaw PX, Mulder WJ, Choi SH, Vucic E, Aguinaldo JG, Witztum JL, Fuster V, Tsimikas S, Fayad ZA. Briley-Saebo KC, et al. Among authors: witztum jl. Circulation. 2008 Jun 24;117(25):3206-15. doi: 10.1161/CIRCULATIONAHA.107.757120. Epub 2008 Jun 9. Circulation. 2008. PMID: 18541740 Free PMC article.

2

Radiolabeled MDA2, an oxidation-specific, monoclonal antibody, identifies native atherosclerotic lesions in vivo.

Tsimikas S, Palinski W, Halpern SE, Yeung DW, Curtiss LK, Witztum JL. Tsimikas S, et al. Among authors: witztum jl. J Nucl Cardiol. 1999 Jan-Feb;6(1 Pt 1):41-53. doi: 10.1016/s1071-3581(99)90064-8. J Nucl Cardiol. 1999. PMID: 10070840

3

In vivo uptake of radiolabeled MDA2, an oxidation-specific monoclonal antibody, provides an accurate measure of atherosclerotic lesions rich in oxidized LDL and is highly sensitive to their regression.

Tsimikas S, Shortal BP, Witztum JL, Palinski W. Tsimikas S, et al. Among authors: witztum jl. Arterioscler Thromb Vasc Biol. 2000 Mar;20(3):689-97. doi: 10.1161/01.atv.20.3.689. Arterioscler Thromb Vasc Biol. 2000. PMID: 10712392

4

Natural antibodies with the T15 idiotype may act in atherosclerosis, apoptotic clearance, and protective immunity.

Shaw PX, Hörkkö S, Chang MK, Curtiss LK, Palinski W, Silverman GJ, Witztum JL. Shaw PX, et al. Among authors: witztum jl. J Clin Invest. 2000 Jun;105(12):1731-40. doi: 10.1172/JCI8472. J Clin Invest. 2000. PMID: 10862788 Free PMC article.

5

Immunological responses to oxidized LDL.

Hörkkö S, Binder CJ, Shaw PX, Chang MK, Silverman G, Palinski W, Witztum JL. Hörkkö S, et al. Among authors: witztum jl. Free Radic Biol Med. 2000 Jun 15;28(12):1771-9. doi: 10.1016/s0891-5849(00)00333-6. Free Radic Biol Med. 2000. PMID: 10946219 Review.

6

Circulating autoantibodies to oxidized LDL correlate with arterial accumulation and depletion of oxidized LDL in LDL receptor-deficient mice.

Tsimikas S, Palinski W, Witztum JL. Tsimikas S, et al. Among authors: witztum jl. Arterioscler Thromb Vasc Biol. 2001 Jan;21(1):95-100. doi: 10.1161/01.atv.21.1.95. Arterioscler Thromb Vasc Biol. 2001. PMID: 11145939

7

Anticardiolipin antibodies from patients with the antiphospholipid antibody syndrome recognize epitopes in both beta(2)-glycoprotein 1 and oxidized low-density lipoprotein.

Hörkkö S, Olee T, Mo L, Branch DW, Woods VL Jr, Palinski W, Chen PP, Witztum JL. Hörkkö S, et al. Among authors: witztum jl. Circulation. 2001 Feb 20;103(7):941-6. doi: 10.1161/01.cir.103.7.941. Circulation. 2001. PMID: 11181467

8

Measuring circulating oxidized low-density lipoprotein to evaluate coronary risk.

Tsimikas S, Witztum JL. Tsimikas S, et al. Among authors: witztum jl. Circulation. 2001 Apr 17;103(15):1930-2. doi: 10.1161/01.cir.103.15.1930. Circulation. 2001. PMID: 11306518 No abstract available.

9

Human-derived anti-oxidized LDL autoantibody blocks uptake of oxidized LDL by macrophages and localizes to atherosclerotic lesions in vivo.

Shaw PX, Hörkkö S, Tsimikas S, Chang MK, Palinski W, Silverman GJ, Chen PP, Witztum JL. Shaw PX, et al. Among authors: witztum jl. Arterioscler Thromb Vasc Biol. 2001 Aug;21(8):1333-9. doi: 10.1161/hq0801.093587. Arterioscler Thromb Vasc Biol. 2001. PMID: 11498462

10

Innate and acquired immunity in atherogenesis.

Binder CJ, Chang MK, Shaw PX, Miller YI, Hartvigsen K, Dewan A, Witztum JL. Binder CJ, et al. Among authors: witztum jl. Nat Med. 2002 Nov;8(11):1218-26. doi: 10.1038/nm1102-1218. Nat Med. 2002. PMID: 12411948 Review. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

477 results

Search Page